These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 10407781)

  • 21. Differentiation of long-chain fatty acid oxidation disorders using alternative precursors and acylcarnitine profiling in fibroblasts.
    Roe DS; Yang BZ; Vianey-Saban C; Struys E; Sweetman L; Roe CR
    Mol Genet Metab; 2006 Jan; 87(1):40-7. PubMed ID: 16297647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A method for quantitative acylcarnitine profiling in human skin fibroblasts using unlabelled palmitic acid: diagnosis of fatty acid oxidation disorders and differentiation between biochemical phenotypes of MCAD deficiency.
    Okun JG; Kölker S; Schulze A; Kohlmüller D; Olgemöller K; Lindner M; Hoffmann GF; Wanders RJ; Mayatepek E
    Biochim Biophys Acta; 2002 Oct; 1584(2-3):91-8. PubMed ID: 12385891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Metabolic Defects in Fatty Acid Oxidation Using Peripheral Blood Mononuclear Cells Loaded with Deuterium-Labeled Fatty Acids.
    Yuasa M; Hata I; Sugihara K; Isozaki Y; Ohshima Y; Hara K; Tajima G; Shigematsu Y
    Dis Markers; 2019; 2019():2984747. PubMed ID: 30881520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heat stress deteriorates mitochondrial beta-oxidation of long-chain fatty acids in cultured fibroblasts with fatty acid beta-oxidation disorders.
    Li H; Fukuda S; Hasegawa Y; Purevsuren J; Kobayashi H; Mushimoto Y; Yamaguchi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(20):1669-72. PubMed ID: 20207594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sudden infant death syndrome and inherited disorders of fatty acid beta-oxidation.
    Harpey JP; Charpentier C; Paturneau-Jouas M
    Biol Neonate; 1990; 58 Suppl 1():70-80. PubMed ID: 2265221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment recommendations in long-chain fatty acid oxidation defects: consensus from a workshop.
    Spiekerkoetter U; Lindner M; Santer R; Grotzke M; Baumgartner MR; Boehles H; Das A; Haase C; Hennermann JB; Karall D; de Klerk H; Knerr I; Koch HG; Plecko B; Röschinger W; Schwab KO; Scheible D; Wijburg FA; Zschocke J; Mayatepek E; Wendel U
    J Inherit Metab Dis; 2009 Aug; 32(4):498-505. PubMed ID: 19452263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physiological Perspectives on the Use of Triheptanoin as Anaplerotic Therapy for Long Chain Fatty Acid Oxidation Disorders.
    Sklirou E; Alodaib AN; Dobrowolski SF; Mohsen AA; Vockley J
    Front Genet; 2020; 11():598760. PubMed ID: 33584796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitochondrial fatty acid oxidation disorders: pathophysiological studies in mouse models.
    Spiekerkoetter U; Wood PA
    J Inherit Metab Dis; 2010 Oct; 33(5):539-46. PubMed ID: 20532823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inborn Errors of Metabolism with Myopathy: Defects of Fatty Acid Oxidation and the Carnitine Shuttle System.
    El-Gharbawy A; Vockley J
    Pediatr Clin North Am; 2018 Apr; 65(2):317-335. PubMed ID: 29502916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The inborn errors of mitochondrial fatty acid oxidation.
    Vianey-Liaud C; Divry P; Gregersen N; Mathieu M
    J Inherit Metab Dis; 1987; 10 Suppl 1():159-200. PubMed ID: 3119938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The changing face of disorders of fatty acid oxidation.
    Vockley J
    Mayo Clin Proc; 1994 Mar; 69(3):249-57. PubMed ID: 8133663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective treatment in carnitine-acylcarnitine translocase deficiency.
    Pierre G; Macdonald A; Gray G; Hendriksz C; Preece MA; Chakrapani A
    J Inherit Metab Dis; 2007 Oct; 30(5):815. PubMed ID: 17508264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurological outcome in long-chain hydroxy fatty acid oxidation disorders.
    Mütze U; Ottenberger A; Gleich F; Maier EM; Lindner M; Husain RA; Palm K; Beblo S; Freisinger P; Santer R; Thimm E; Vom Dahl S; Weinhold N; Grohmann-Held K; Haase C; Hennermann JB; Hörbe-Blindt A; Kamrath C; Marquardt I; Marquardt T; Behne R; Haas D; Spiekerkoetter U; Hoffmann GF; Garbade SF; Grünert SC; Kölker S
    Ann Clin Transl Neurol; 2024 Apr; 11(4):883-898. PubMed ID: 38263760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Familial infantile apnea and immature beta oxidation.
    Iafolla AK; Browning IB; Roe CR
    Pediatr Pulmonol; 1995 Sep; 20(3):167-71. PubMed ID: 8545168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retrospective biochemical screening of fatty acid oxidation disorders in postmortem livers of 418 cases of sudden death in the first year of life.
    Boles RG; Buck EA; Blitzer MG; Platt MS; Cowan TM; Martin SK; Yoon H; Madsen JA; Reyes-Mugica M; Rinaldo P
    J Pediatr; 1998 Jun; 132(6):924-33. PubMed ID: 9627580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondrial fatty-acid oxidation disorders.
    Kompare M; Rizzo WB
    Semin Pediatr Neurol; 2008 Sep; 15(3):140-9. PubMed ID: 18708005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implications of impaired ketogenesis in fatty acid oxidation disorders.
    Olpin SE
    Prostaglandins Leukot Essent Fatty Acids; 2004 Mar; 70(3):293-308. PubMed ID: 14769488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long chain fatty acid oxidation defects in children: importance of detection and treatment options.
    Hayes B; Lynch B; O'Keefe M; Monavari AA; Treacy EP
    Ir J Med Sci; 2007 Sep; 176(3):189-92. PubMed ID: 17431731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel functional assay for simultaneous determination of total fatty acid beta-oxidation flux and acylcarnitine profiling in human skin fibroblasts using (2)H(31)-palmitate by isotope ratio mass spectrometry and electrospray tandem mass spectrometry.
    Law LK; Tang NL; Hui J; Ho CS; Ruiter J; Fok TF; Wanders RJ; Lam CW
    Clin Chim Acta; 2007 Jul; 382(1-2):25-30. PubMed ID: 17442290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-invasive test using palmitate in patients with suspected fatty acid oxidation defects: disease-specific acylcarnitine patterns can help to establish the diagnosis.
    Janzen N; Hofmann AD; Schmidt G; Das AM; Illsinger S
    Orphanet J Rare Dis; 2017 Dec; 12(1):187. PubMed ID: 29268767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.